Navigation Links
UW discovery could lead to new TB treatments

tegrity of its cell walls. Enzymes are proteins that initiate chemical reactions within plant and animal cells.

"We've figured out how this enzyme works. If you knock it out, the bacteria aren't viable," Kiessling explains. "It's an essential enzyme."

The TB microbe's success and resistance to traditional drugs is attributed in large measure to its multilayered cell wall, compose......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 05/10/04


Page: 1 2 3

Related biology technology :

1. A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology
2. Finding Safe Harbor in a sea of electronic discovery
3. Quick peeks, Clawback Agreements, and the rules of electronic discovery
4. Researcher wants to commercialize adult stem cell discovery
5. Madison biotech introduces drug discovery advance
6. Avoiding the electronic discovery trap
7. The 3 percent solution: Unpopular drug companies still push discovery
8. Human stem cells called great opportunity for drug discovery
9. Medical College researchers receive new grants to enhance discovery of heart-protecting anesthetics
10. Medical College discovery leads to new stents
11. IRS ruling could speed healthcare technology adoption
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: discovery could lead new treatments

(Date:12/16/2009)... Dec. 16 WaferGen Biosystems, Inc. (OTC ... genetic analysis systems, today announced that it will ... innovative service for gene-expression profiling using its SmartChip(TM) ... provides the most comprehensive human microRNA panel of ... company,s SmartChip service offers customers the use of ...
(Date:12/16/2009)... -- Capitalizing on the continued strong growth ... venture capital market, leaders from BioCrossroads, Eli Lilly ... University, Purdue University, the University of Notre Dame, ... announced the establishment of the INext Fund, a ... Organized through BioCrossroads, Indiana,s initiative to grow, expand ...
(Date:12/16/2009)... to Special Protocol Assessment with the Food ... 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... a global biopharmaceutical company focused on oncology ... by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ... clinical trial for perifosine (KRX-0401), the Company,s ...
(Date:12/16/2009)... American Filtration and Separations Society will hold its 23rd Annual Technical ... Hotel in San Antonio, Texas. To further impact the separation society ... are proud to announce that the 2010 AFS Annual Technical Conference ... , ... Minneapolis, MN (PRWEB) December 16, 2009 -- ...
Breaking Biology Technology:WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4
... First Provider of Clinical Documentation Technology, ... ... Spheris has been selected as,the first awarded supplier of medical ... group purchasing organizations.,Under the parties, agreement, Spheris will provide Provista ...
... 2:00 pm ET on November 27, 2007, CAMBRIDGE, ... ) today announced its participation,in the Lazard Capital Markets ... 2007 at the New York Palace Hotel in New ... will be presenting at 2:00 pm ET on Tuesday, ...
... TORONTO, Nov. 20 /PRNewswire-FirstCall/ - ARIUS Research ... developing the next wave of,antibody therapeutics, today ... of Research, will present at the 14th ... Pereira will present on,ARIUS, non-traditional approach to ...
Other Biology Technology:Provista Awards Agreement to Spheris 2Targanta to Present at Lazard Capital Markets Fourth Annual Healthcare Conference 2ARIUS to present at BioNorth Biotechnology and Life Sciences Conference 2
(Date:12/16/2009)... -- BIO-key International, Inc. (OTC Bulletin Board: ... solutions, today announced that SC Magazine, one ... named BIO-key International the 2009 Innovator of ... Biometrics. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) ... SC Magazine, "Biometric providers have been trying ...
(Date:12/15/2009)... GAINESVILLE, Fla. When treating devastating brain diseases such ... medical bags to find something to help a patient. ... to help the vast majority of patients with ataxia ... and coordination. , University of Florida neurologists are trying ... million Challenge grant from the National Institute of Neurological ...
(Date:12/15/2009)... mammoths and ancient American horses may have been ... years longer than previously thought. After plucking ancient ... team of researchers used cutting-edge techniques to uncover ... samples dated to between 7,600 and 10,500 calendar ... one population of these now-extinct mammals endured longer ...
Breaking Biology News(10 mins):BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head Product 26 Portfolio Strategy 13965 1PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head Product 26 Portfolio Strategy 13965 2 C O R R E C T I O N Clinical Therapeutics 13962 1 C O R R E C T I O N Clinical Therapeutics 13962 2 C O R R E C T I O N Clinical Therapeutics 13962 3 C O R R E C T I O N Clinical Therapeutics 13962 4 C O R R E C T I O N Clinical Therapeutics 13962 5Kapstone Medical Acquires Exclusive License to New Orthopedic Technology 56715 1Kapstone Medical Acquires Exclusive License to New Orthopedic Technology 56715 2
... release is available in Spanish . , ... has studied the origin of the mutation that causes Fatal Familiar ... is a high rate of carriers of this mutation 50%of ... Fatal Familiar Insomnia (FFI) is one of the diseases considered as ...
... HIGHLIGHTS BREAKTHROUGH RESEARCH IN UNDERSTANDING GENETIC AND SOCIOECONOMIC ... , Although racial and ethnic differences in treatment ... little is understood about the underlying causes and ... intractable problem. The American Association for Cancer Research ...
... An international group of scientists is linking nutrient pollution ... number of harmful algal blooms reported in recent years. When ... cause human respiratory and skin irritations and cause fish or ... edition of the journal Harmful Algae , scientists present ...
Other Biology News:Study on origin of mutation that causes fatal familiar insomnia 2Study on origin of mutation that causes fatal familiar insomnia 3American Association for Cancer Research hosts Science of Health Care Disparities Meeting 2
... are at least 20 structurally and functionally ... TGF-beta superfamily. BMPs were originally identified as ... They are also involved in embryogenesis and ... regulate the growth, differentiation, chemotaxis and apoptosis ...
dynactin 4, mRNA (cDNA clone MGC:3248 IMAGE:3505855), complete cds...
RABBIT ANTI HUMAN TRRAP (CT) Immunogen: Recombinant C-terminal kinase-related domain of human TRRAP....
One-step, microplate or cuvet, colorimetric, detection range 0.01 g/dL to 5 g/dL. Procedure: 5 min....
Biology Products: